FDA Sued Over Delay On Pfizer Alzheimer's Drug Decision

Law360, New York (September 5, 2012, 3:36 PM EDT) -- A consumer advocacy group sued the U.S. Food and Drug Administration Wednesday in Washington federal court, in a bid to force the agency to decide on its petition to pull a Pfizer Inc. Alzheimer's drug from the market over efficacy and safety concerns.

Public Citizen Inc. filed a petition with the FDA in May 2011 that contended a 23-milligram dose of Aricept, manufactured by Eisai Co. Ltd. and marketed by Pfizer, failed to meet agency-required efficacy criteria for dementia drugs. The dose also demonstrated significantly more...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

PUBLIC CITIZEN, INC. v. FOOD AND DRUG ADMINISTRATION


Case Number

1:12-cv-01461

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Judge

Colleen Kollar-Kotelly

Date Filed

September 5, 2012

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.